TREATMENT OF UNRESECTABLE HEPATOCELLULAR-CARCINOMA WITH A COMBINATION OF HUMAN RECOMBINANT ALPHA-2B INTERFERON AND DOXORUBICIN - RESULTS OF A PILOT-STUDY

被引:7
|
作者
LOTZ, JP
GRANGE, JD
HANNOUN, L
BOUDGHENE, F
AMIOT, X
LAMARQUE, D
ANDRE, T
ESTESO, A
BELLAICHE, A
BOULEUC, C
BODIN, F
PARC, R
BIGOT, JM
IZRAEL, V
机构
[1] HOP TENON,SERV GASTROENTEROL,F-75970 PARIS 20,FRANCE
[2] HOP TENON,SERV RADIOL,F-75970 PARIS 20,FRANCE
[3] HOP ST ANTOINE,SURG SERV,F-75012 PARIS,FRANCE
关键词
HEPATOCELLULAR CARCINOMA; DOXORUBICIN; INTERFERON;
D O I
10.1016/0959-8049(94)90181-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Based on the in vitro and in vivo potentiation of the cytotoxic activity of chemotherapeutic agents by the interferons, a pilot study combining human recombinant alpha-2b interferon (IFN) and doxorubicin was conducted for the treatment of unresectable, histologically proven hepatocellular carcinoma. Between March 1988 and May 1990, 21 patients (median age: 60 years, range: 29-76) entered the study. The dose of doxorubicin was fixed at 35 mg/m(2), every 3 weeks. The dose of alpha-2b IFN was 6 million U/m(2) per day, 5 days a week. 3 patients (14%) obtained a partial response lasting 11, 16 and 30 months, and 1 had a stable disease during 8 months. The other 17 patients died within a median survival time of 4 months. All patients experienced flu-like symptoms. 7 patients experienced WHO grade III-IV haematological toxicity. We conclude that the association of alpha-2b IFN and doxorubicin is feasible, with respect to the use of doxorubicin at an inferior dose level than the same agent used without IFN. The response rate is comparable to that observed with doxorubicin used alone. Further phase I studies and randomised trials are required to confirm the role of this regimen in the treatment of unresectable hepatocellular carcinoma.
引用
收藏
页码:1319 / 1325
页数:7
相关论文
共 50 条
  • [1] RECOMBINANT HUMAN GAMMA - INTERFERON IN THE TREATMENT OF HEPATOCELLULAR-CARCINOMA - PRELIMINARY-RESULTS OF A PILOT-STUDY
    MAZZANTI, R
    PINZANI, M
    ZIGNEGO, L
    ROMANELLI, R
    GENTILINI, P
    [J]. DIGESTIVE DISEASES AND SCIENCES, 1986, 31 (10) : S131 - S131
  • [2] TREATMENT OF HEPATOCELLULAR-CARCINOMA WITH RECOMBINANT LEUKOCYTE INTERFERON - A PILOT-STUDY
    SACHS, E
    DIBISCEGLIE, AM
    DUSHEIKO, GM
    SONG, E
    LYONS, SF
    SCHOUB, BD
    KEW, MC
    [J]. BRITISH JOURNAL OF CANCER, 1985, 52 (01) : 105 - 109
  • [4] PROLONGED PARTIAL RESPONSE OF HEPATOCELLULAR-CARCINOMA WITH DOXORUBICIN AND RECOMBINANT HUMAN INTERFERON ALPHA-2
    AMIOT, X
    GRANGE, JD
    BOUDGHENE, F
    LAMARQUE, D
    LOTZ, JP
    IZRAEL, V
    BODIN, F
    [J]. ANNALES DE GASTROENTEROLOGIE ET D HEPATOLOGIE, 1991, 27 (05): : 211 - 214
  • [5] METHIMAZOLE IN THE TREATMENT OF HEPATOCELLULAR-CARCINOMA (A PILOT-STUDY)
    PASCASIO, FM
    DOMINGO, EO
    LAO, JY
    MANIPOL, VC
    CRUZ, FB
    [J]. PHILIPPINE JOURNAL OF INTERNAL MEDICINE, 1981, 19 (02): : 80 - 84
  • [6] Treatment of advanced medullary thyroid carcinoma with a combination of recombinant interferon alpha-2b and octreotide
    Lupoli, G
    Cascone, E
    Arlotta, F
    Vitale, G
    Celentano, L
    Salvatore, M
    Lombardi, G
    [J]. CANCER, 1996, 78 (05) : 1114 - 1118
  • [7] B-CLL IN EARLY PHASE RESPONDS TO RECOMBINANT ALPHA-2B INTERFERON THERAPY AS DETERMINED IN A PILOT-STUDY
    THIEL, E
    SCHLAG, R
    HILL, W
    KETTNER, G
    FLIEGER, D
    ZIEGLER, HWL
    [J]. BLUT, 1987, 55 (04): : 243 - 243
  • [8] ARSENIC TRIOXIDE PLUS CISPLATIN/INTERFERON ALPHA-2B/DOXORUBICIN/CAPECITABINE IN VITRO COMBINATION CHEMOTHERAPY FOR HEPATOCELLULAR CARCINOMA
    Tomuleasa, Ciprian
    Soritau, Olga
    Fischer-Fodor, Eva
    Pop, Teodora
    Mosteanu, Ofelia
    Pintea, Bogdan
    Kacso, Gabriel
    Irimie, Alexandru
    Acalovschi, Monica
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1095 - 1095
  • [9] Clinical pilot study of methotrexate-5fluorouracil, cisplatin, and interferon alpha-2b combination treatment for patients with advanced hepatocellular carcinoma.
    Urabe, T
    Kaneko, S
    Nakahama, R
    Minouchi, K
    Kitano, Y
    Terasaki, S
    Kawai, H
    Shimoda, A
    Matsushita, E
    Unoura, M
    Kobayashi, K
    [J]. HEPATOLOGY, 1996, 24 (04) : 1862 - 1862
  • [10] TREATMENT OF MYCOSIS-FUNGOIDES WITH RECOMBINANT ALPHA-2B INTERFERON IN COMBINATION WITH ETRETINATE
    STAVRIANEAS, N
    KATSAMBAS, A
    VARELTZIDES, A
    STAVROPOULOS, P
    POLYDOROU, D
    ZIKA, P
    STRATIGOS, J
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1989, 93 (04) : 580 - 580